Breadcrumb

CIM News

Significant funding to maximize access and drive excellence in clinical trials in Quebec and Canada

RI-MUHC researchers will lead or co-lead multiple projects awarded a total of $55 million from the Canadian Institutes...

Triple-negative breast cancer: the RI-MUHC enrolls first patients in international Phase 3 clinical trial

The first participants in this large study were recently selected at the Cedars Cancer Centre of the MUHC.

The 2022 RI-MUHC Annual Report is online!

An invitation from Dr. Rhian Touyz

An Equity, Diversity and Inclusion Action Plan for the RI-MUHC

The plan prioritizes six groups traditionally underrepresented in research

Summer Student Research Day returns to the RI-MUHC

A diverse group of young research trainees present their summer projects

A first large detailed description of the worldwide 2022 monkeypox outbreak

MUHC physicians made important contributions to a new article published in the New England Journal of Medicine

Immunotherapy showing significant advancements in lung cancer treatment

Phase 3 clinical trial of neoadjuvant nivolumab leads to practice-changing results

TB and COVID-19, a joint battle?

On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.

What’s the signature of a healthy heart?

Instead of treating the “average person,” the Courtois Cardiovascular Signature Program aims to treat every person as a unique individual

Raquel del Carpio-O’Donovan elected Honorary President by the World Federation of Neuroradiological Societies

World-class neuroradiologist regards her career as “an enormous fortune”

Explore news and events at the RI-MUHC